ACADIA PHARMACEUTICALS INC ($ACAD)
Filing Information
| Accession Number | 0001861477-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 27, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
16,865
Total Value
$73,749.45
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Head of Research & Dev | Common Stock | โ | Mar 24, 2026 | Exercise/Conversion | 6,715 | โ | โ | 6,715 | Direct | โ | View Details | |
EVP, Head of Research & Dev | Common Stock | โ | Mar 25, 2026 | Sale | 3,435 | $21.47 | $73,749.45 | 3,280 | Direct | โ | View Details | |
EVP, Head of Research & Dev | Restricted Stock Units | Derivative | Mar 24, 2026 | Exercise/Conversion | 6,715 | $0.00 | $0.00 | 20,146 | Direct | โ | View Details |